XML 36 R26.htm IDEA: XBRL DOCUMENT

Note 8 - Financial Instruments With Off-balance-sheet Risk (Tables)

3 Months Ended

Mar. 31, 2023

Notes Tables

Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block]

		March 31, 2023								December 31, 2022
						Fair Value of								Fair Value of
						Unfunded								Unfunded
		*Principal*				*Commitment*				*Principal*				*Commitment*
		*Balance*				*Liability*				*Balance*				*Liability*
		(In thousands)								(In thousands)
BrightInsight, Inc.		$	18,250			$	241			$	21,000			$	278
Britecore Holdings, Inc.			—				—				5,000				66
Castle Creek Biosciences			4,000				72				4,000				72
Corinth Medtech, Inc.			200				—				—				—
Divergent Technologies, Inc.			18,750				197				22,500				236
Engage3, LLC			8,000				40				8,000				40
Groundspeed Analytics, Inc.			15,500				150				15,000				150
Hound Labs, Inc.			7,500				88				7,500				88
KSQ Therapeutics, Inc.			10,000				100				10,000				100
Lytics, Inc.			4,000				52				5,000				65
Native Microbials, Inc.			—				—				7,500				72
Noodle Partners, Inc.			10,000				123				—				—
Optoro, Inc.			15,000				38				15,000				38
PDS Biotechnology Corporation			10,000				158				10,000				158
Robin Healthcare, Inc.			5,000				50				10,000				100
Scientia Vascular, Inc.			10,000				110				10,000				110
Slingshot Aerospace, Inc.			5,000				63				5,000				64
Swift Health Systems Inc.			18,500				—				25,500				105
Temperpack Technologies, Inc.			6,500				14				9,000				19
Total		$	166,200			$	1,496			$	190,000			$	1,761